The AHA Guidelines and Scientific Statements Handbook

Index

Bartonella 318, 327–8
cause 314
culture-negative 321–2, 327, 329, 332
diagnosis 312
enterococcal 335
experimental 315, 332
infective 319–343
prophylaxis 333
prosthetic valve 293, 309, 319, 321, 325–6
enterococcal 322–5
valve
native 299 309
prosthetic 309–10
Endocrine disorders 211–2, 271, 282–3
Endocrinopathy 282
Endomyocardial fi brosis 241
Endothelin 226
Energy, estimated requirements 157
Enoxaparin 30, 32, 35–8, 42, 45, 63, 89, 127
ENRICHD Trial 221
Enterobacteriaceae 318
Enterococci 314, 316, 318, 322, 329–30
Epinephrine 75
Eplerenone 209–10, 227
Eprosartan 227
Epsilon-aminocaproic acid 141
Eptifi batide 35–7, 64, 130
Erythromycin 290
Erythropoiesis 232
Esmolol 209
Esophagogastroduodenoscopy 334
ESRD 134, 143, 219, 283, 291
Estrogens 192
Etexilate, dabigatran 254
European Atrial Fibrillation Trial 247–8
European Myocardial Infarction Amiodarone Trial 281
European Stroke Prevention Study 248
Event, thromboembolic 232
Evidence
-based grading system 332
pathological 313–4
serological 314
Exercise 6–8, 10–1, 296–7, 300–1, 303–5, 307
after cardiac rehabilitation 104
antiarrthymic effects of, after ICD 104
stress 299
testing 81, 270, 273–4, 298, 301
tolerance 305
training 98
Ezetimibe 190

Fabry disease 241
Fats, saturated 191, 218–9

Fatty acids 291

omega-3 67, 109, 217–8

polyunsaturated 189, 288

trans- 109, 189

Fenofi brate 190

Fibrate 192

Fibrillation 46, 65–6, 68, 74–5, 86

Fibrinolysis 52–3, 55–64, 68, 70, 72–3, 78–9, 82–3, 88,

124, 127

Fibroelastosis 241

First Line Radiofrequency Ablation versus Antiarrhythmic

Drugs for Atrial Fibrillation Treatment trial

254

Fistulae 316, 325

arteriovenous 344

Flecainide 249–51, 253, 259, 261–5, 267–8

5-fl uorouracil 291

Flutter, atrial 247, 252, 255, 257, 266–8, 291

Fluvastatin 190

Focal atrial tachycardias 256, 263–6

Focal junctional tachycardia 262

Folic acid 216, 220

Fondaparinux 26, 32, 35–8, 42, 45, 63, 68, 89, 127

Fosinopril 227

Framingham Heart Study 198, 205–6

Framingham Risk Score 198, 202, 205, 214–5, 338

Fugax 53

Function

impaired LV 275

renal 136

RV 274

ventricular 270, 274, 282, 289, 291

Furosemide 70, 228

Gallstones 190, 193

Gangrene 171, 182

Gaucher disease 241

Gemfi brozil 190

Genes 238–41

Genitourinary tract 332

Gentamicin 315, 317–24, 327–8

German Atrial Fibrillation Network 254

Global Registry of Acute Coronary Events 31

Glomerular fi ltration rate 202, 210–1

Glomerulonephritis 314

Glucocorticoid 140, 212

-remediable aldosteronism 212

Glucose 57, 64, 162, 193, 202

Glutaryl, hydroxymethyl 173

Glycohemoglobin 225

Glycoprotein 117

“golden hour” 50

Gout 190